Medivera Compounding Pharmacy

Pharmacy at a glance

Accreditations & quality standards

Medivera Compounding Pharmacy maintains the following accreditations and operates under the following quality standards:

PCAB (Pharmacy Compounding Accreditation Board) is a third-party accreditation administered by the Accreditation Commission for Health Care (ACHC). USP <797> is the United States Pharmacopeia chapter governing sterile compounding.

What Medivera Compounding Pharmacy compounds

Compounds sterile injectable preparations including tirzepatide and semaglutide on a patient-specific 503A basis. USP <797> sterile compounding workflow.

Transparency & documentation

Pharmacy license and PCAB accreditation publicly verifiable. Quality documentation provided on request.

For tirzepatide and semaglutide preparations, ask your prescribing telehealth provider for:

• The dispensing pharmacy of record on every shipment label
• Per-vial lot number traceability
• Certificate of Analysis (CoA) showing USP <71> sterility, USP <85> bacterial endotoxin, and HPLC potency assay results
• API source disclosure (tirzepatide base, not unrecognized salt forms)
• Documented recall pathway

Telehealth providers using Medivera Compounding Pharmacy

Medivera Compounding Pharmacy is publicly disclosed by the following telehealth providers in TirzepatideReview.com's directory:

• NexLife — #1 editorial pick (94/100). NexLife discloses dual 503A and 503B pharmacy partners on every shipment.

Pharmacy assignment for any individual patient depends on prescription specifics, dose, and shipment routing. Always confirm the dispensing pharmacy on your specific shipment label.

Where Medivera Compounding Pharmacy fits in the v3.0 transparency rubric

The TirzepatideReview.com v3.0 rubric scores telehealth providers (not pharmacies directly) on six pillars. Pillar 2 — Pharmacy traceability and CoA evaluates whether the provider publicly identifies its pharmacy of record, supports per-vial lot traceability, and supplies USP <71>, USP <85>, and HPLC potency CoAs on patient request. Medivera Compounding Pharmacy's 503A Compounding status, PCAB, USP <797>, and quality documentation directly contribute to the Pillar 2 scores of providers that use this pharmacy.